Statement from Global Down Syndrome Foundation Executive Director Michelle Sie Whitten on Thai surrogacy case
August 4th, 2014 by Global Down Syndrome Foundation
Statement from Global Down Syndrome Foundation Executive Director Michelle Sie Whitten in response to the story of a surrogate baby with Down syndrome in Thailand whose surrogate mother says was abandoned by his parents:
The discrimination against people with Down syndrome, even in developed nations, is profound. The abandonment of a surrogate twin boy with Down syndrome to life or death in Thailand clearly underscores this.
The reality is the condition is almost completely different from what it was just 20 years ago. For example, the lifespan of a person with Down syndrome in the 1980s was 28 years old, and today it is nearly 60. And according to a national U.S. poll commissioned by the Global Down Syndrome Foundation, over three-quarters of Americans believe people with Down syndrome have the right to vote, buy a home and get married, with 97 percent of Americans agreeing that people with Down syndrome should have the chance to hold a job and deserve fundamental human and civil rights.
As a first-generation American, Executive Director of the Global Down Syndrome Foundation, a women’s rights advocate living in the 21st century, and a mother of a child with Down syndrome and her typical brother, I would hope that accurate information about Down syndrome would have steered this headline-making Australian couple toward a different, if not educated, decision.
Watch CBS4′s Kathy Walsh interview Global Executive Director Michelle Sie Whitten about the case:
August 3rd, 2014 by Global Down Syndrome Foundation
Award-winning actor John C. McGinley expounds on his hit TV show “Ground Floor,” working with Oliver Stone, being an international spokesperson for the Global Down Syndrome Foundation, and his most important role – being a dad to Max, who happens to have Down syndrome. McGinley is also a Global board member and a recipient of Global’s Quincy Jones Exceptional Advocacy Award. McGinley is truly a Global hero. Learn more by watching his Global Tribute Video.
1. You play the tycoon Remington Stewart Mansfield on the new hit comedy Ground Floor, which is getting ready to return for its second season on TBS. Tell us what people love about this prickly hilarious character.
2. What is it like working with Skylar Astin (Brody), Briga Heelan (Jennifer) and the rest of the talented cast on Ground Floor? Are you ever forced to break into song?
3. You have an illustrious film career, including starring in seven Oliver Stone films (Platoon, Wall Street, Any Given Sunday, World Trade Center, Nixon, Born on the Fourth of July, Talk Radio). What was it like working with such a legendary director on such important films?
4. For 10 years, you starred as the acerbic and loveable Dr. Perry Cox on the Emmy Award-winning Scrubs. What is your favorite memory from the Scrubs set?
5. In addition to your award-winning acting career, you are a dedicated husband and father. What’s your secret to balancing work and home life?
6. Your son Max turns 17 this month. He happens to have Down syndrome. How has that influenced you as a father and as a person?
7. You are a board member and International Spokesperson for the Global Down Syndrome Foundation. Why should people support Global and the work they do?
8. You are a regular at Global’s award-winning event, the Be Beautiful Be Yourself Fashion Show. What is so special about this event?
9. In addition to your work with Global, you are a Global Ambassador for Special Olympics and have been an integral part of the “Spread the Word to End the Word” campaign. (Read John’s commentary on the issue from The Huffington Post.) What are your hopes for this campaign’s future and its impact?
10. What is the best advice you were ever given that you would like to pass on?
August 1st, 2014 by Global Down Syndrome Foundation
Children from across the United States are benefiting from the efforts of the multi-disciplinary team at the Anna and John J. Sie Center for Down Syndrome at Children’s Hospital Colorado.
The Global Down Syndrome Foundation is a founding donor of the Sie Center and continues to provide financial and advocacy support.
Since opening in 2011, the Sie Center has grown to be one of the largest centers in the United States that specializes in treating children with Down syndrome.
“We see patients from 24 states, especially Colorado and its neighbors,” said Fran Hickey, M.D., Medical Director of the Sie Center and Associate Professor of Pediatrics at Children’s Hospital Colorado. “Our center is really unique because of the collaboration in the hospital and the emphasis on excellent medical care and clinical research.”
A Multi-disciplinary Team and Subspecialty Care
The Sie Center has a multi-disciplinary team of 13 professionals working full-time treating patients with Down syndrome. Medical care, speech therapy, physical therapy, behavioral support, nutrition, assistive technology, social work and access to resources are integrated for each child.
The Sie Center also benefits from being housed in a top ten children’s hospital. Located at the Children’s Hospital Colorado, the Sie Center’s patients have access to over 20 subspecialists at the hospital, who focus on areas such as cardiology, sleep disorders, audiology, otolaryngology, and endocrinology. This is important since children with Down syndrome often are at increased risk for congenital heart conditions, leukemia, autoimmune disorders and sleep apnea.
“We have built a team of professionals dedicated to and passionate about children with Down syndrome,” said Patricia Winders, P.T., Senior Physical Therapist and Director of Therapies at the Sie Center. “This team embodies the difference between going to a typical physician appointment and being referred to specialists in different locations, compared to visiting one place where a group of medical professionals look at your whole child and collaborate about your child’s care. Our families tell us we make them feel at home, listened to, and well cared for.”
Establishing a Baseline for Life-long Health
The medical professionals at the Sie Center have well over 100 years combined experience specializing in care for children with Down syndrome. Winders, who has just completed her 2nd edition of Gross Motor Skills for Children with Down Syndrome, has over 30 years of experience in treating children with this diagnosis. Her focus is on creating a healthy foundation for posture and movement, and a positive encouraging environment to meet milestones.
“We help children develop the strength, posture and motor skills they will need to be active as adolescents and beyond, so that as they mature, they can choose to do what they love,” she said.
Dr. Hickey and others at the Sie Center are designing and engaged in clinical research studies that will address a variety of issues including sleep apnea, swallow and feeding issues, pain management, and autoimmune disorders. Currently, Down syndrome research receives the least amount of federal funding of any genetic condition.
“Our research is going to benefit children with Down syndrome and typical children alike, since medical problems such as sleep apnea may affect any pediatric patient,” Dr. Hickey added. “We want to help children and families function as well as possible in every realm — health, education, and social well-being.” With excellent feedback from many of its 1,000 families it is clear the Sie Center and is delivering on its important mission to provide life-changing health care to children with Down syndrome.
To learn more about the multidisciplinary team at the Sie Center or to schedule an appointment, call 720-777-6750 or visit siecenter.org.
July 31st, 2014 by Global Down Syndrome Foundation
The Global Down Syndrome Foundation’s Alzheimer’s disease initiative received a big boost from the state of Colorado this year when Governor John Hickenlooper signed a bill passed by the state legislature that allocates $250,000 to the first Alzheimer’s disease research & clinical center in Colorado.
Senate Bill 14-211 was approved 35-0 by the Colorado Senate and 62-3 by the Colorado House, and was signed into law by Governor Hickenlooper on June 5th. The state’s initial investment of $250,000 will be received in fiscal year 2014. “It is declared to be the policy of this state to achieve the maximum practical degree of care and treatment for persons suffering from Alzheimer’s and related diseases,” the bill states.
The success of the bill is credited to Governor Hickenlooper and bill co-sponsors Senator Michael Johnston, Senator David Balmer, Rep. Dickey Hullinghorst and Rep. Mark Waller. A key issue for legislators is addressing the fact that Colorado is one of the fastest-growing states in terms of Alzheimer’s disease as a percentage of the population. Currently, an estimated 200,000 people in Colorado and adjacent states have Alzheimer’s, at an estimated societal cost of $17 billion a year.
The new Center is housed at the University of Colorado School of Medicine at the Anschutz Medical Campus in Aurora. It is the first such center in a 600-mile radius of Denver and a much needed resource for families in the region.
Huntington Potter, Ph.D., is the founder and director of the Center and was recruited by the Global Down Syndrome Foundation, the Linda Crnic Institute for Down Syndrome, and the Department of Neurology at CU.
Potter is a renowned Alzheimer’s disease researcher who discovered the mechanistic relationship between Alzheimer’s disease and Down syndrome. Unfortunately, 100% of people with Down syndrome have the brain pathology of Alzheimer’s disease and an estimated 50% will develop dementia symptoms before age 50.
People with Down syndrome by definition are born with three copies of chromosome 21 instead of two. People with Alzheimer’s disease have many cells with three copies of chromosome 21. As the amyloid precursor protein gene (APP) resides on chromosome 21, these trisomy 21 cells produce excess APP and its product, the Alzheimer beta peptide, contributing to the development of Alzheimer’s disease pathology.
Recognizing that these conditions are two sides of the same coin and studying them together will hasten the development of new treatments for both. The key is to discover why many people with Down syndrome and some people with typical age-related Alzheimer’s disease can have the pathology in the brain but not develop dementia.
“The support of our state leadership is crucial to ensuring this center’s success,” said Michelle Sie Whitten, executive director of the Global Down Syndrome Foundation, “but we will need broad-based community support as well. Global and CU have a daunting but important task in front of us – to raise awareness and endowed funds to ensure that people in this region with Alzheimer’s disease, including those with Down syndrome, can get the best care and participate in the best trials.”
The CU Department of Neurology has recruited Jonathan Woodcock, M.D., who has already seen close to 1,000 patients, including people with Down syndrome. Potter is also launching the Center’s first clinical trial looking at Leukine in people with early onset of Alzheimer’s disease after his lab discovered the protein that likely explains why people with rheumatoid arthritis rarely get Alzheimer’s disease.
“Our first goal is to create — within the next three years — a comprehensive, nationally recognized Alzheimer’s disease patient care center and research institute that will serve the people of Colorado and surrounding states,” Potter said.
To this end, Potter has submitted a grant to the National Institute on Aging (NIA) for recognition as an Alzheimer’s Disease Research Center of excellence.
Currently, there are 27 NIA-designated Alzheimer’s Disease Research Centers in the United States. An estimated 5.4 million Americans are currently living with Alzheimer’s disease, a number that is expected to more than double by 2050. Annual costs related to Alzheimer’s and other dementias exceed $200 billion.
In 2013, the Global Down Syndrome Foundation, the Linda Crnic Institute and the national Alzheimer’s Association established the Down Syndrome-Alzheimer’s Disease Investigator Program. The program has funded $1.2 million in grants to investigators around the world.
BioFrontiers Institute Launches Inaugural Sie Post-doctoral Fellowship Program; Research Will Focus on Improving the Lives of People with Down syndrome
July 10th, 2014 by Global Down Syndrome Foundation
Crnic Institute-affiliated program names Mary Allen, Geertruida Josien Levenga, Alfonso Garrido-Lecca
DENVER (July 8, 2014) – The BioFrontiers Institute at the University of Colorado launched its inaugural Sie Post-doctoral Fellowship Program in affiliation with the Linda Crnic Institute for Down Syndrome on the Anschutz Medical Campus. The program will fund three post-doctoral researchers, Sie Fellows, who will focus on research that will improve the lives of individuals with Down syndrome.
The Sie Fellows research is co-funded by the BioFrontiers Institute and the Anna and John J. Sie Foundation. Every two years, three Sie Fellows will be selected from a competitive grant process and will receive between $71,000 and $85,000 a year for two years.
Nobel Laureate and head of the BioFrontiers Institute Thomas Cech, BioFrontiers Chief Scientific Officer (CSO) Leslie Leinwand, and Executive Director of the Crnic Institute Tom Blumenthal were key in assessing the 44 applicants prior to deciding on the inaugural three recipients: Mary Allen of CU-Boulder’s Department of Molecular, Cellular and Developmental Biology (MCDB), Geertruida Josien Levenga of CU-Boulder’s Institute of Behavioral Genetics, and Alfonso Garrido-Lecca of MCDB.
“The projects being carried out by the Sie Fellows are key to significantly improving the lives of people with Down syndrome and to eradicating the medical and cognitive ill effects associated with the condition,” said Leinwand. “The support of early-stage post-doctoral fellows is crucial in any research operation, and these awards make it possible for faculty to increase their commitment to this important cause.”
The BioFrontiers Institute was formed in 2011 to bring together faculty members from the life sciences, physical sciences, computer science and engineering with the passion and skills needed to research across traditional disciplines and tackle difficult medical issues, under the leadership of Cech, the institute’s director.
“The research embodies the kind of cutting-edge interdisciplinary approach to biomedical problems that BioFrontiers is all about,” Cech said.
“The fact that there were 44 applicants for three awards underscores how exciting research for Down syndrome is, and the potential for real scientific contribution,” said Blumenthal. “With our Supergroup of 60 scientists working on Down syndrome and meeting monthly from different disciplines and different schools, we are truly making a difference for this special population and their families.”
“The Global Down Syndrome Foundation is pleased to add these outstanding researchers to our future portfolio of research we aim to fund and advocate for. Their research is already so relevant,” said Michelle Sie Whitten, executive director of the Global Down Syndrome Foundation, the fundraising and advocacy arm of the Crnic Institute.
Allen’s research involves genetic sequencing data from people with Down syndrome and their parents to understand how an extra copy of chromosome 21 puts people with Down syndrome at higher risk for health issues such as heart defects, thyroid conditions, leukemia, Alzheimer’s disease, and respiratory and hearing problems, but at lower risk for heart attack, stroke and solid-tumor cancers.
Levenga, who is a neuroscientist, is conducting research into ameliorating the seizures that afflict many people with Down syndrome.
Garrido-Lecca will test the hypothesis that alteration of microRNA levels in people with Down syndrome contributes to some of their health challenges.
Down syndrome is the most commonly occurring chromosomal condition, affecting one out of every 691 live births in the U.S., according to the Centers for Disease Control and Prevention. Because of the end of widespread institutionalization, better medical care, improved access to education and greater societal inclusion, people with Down syndrome are living longer and more productive lives, with the average life span increasing from 25 years in 1983 to 60 years today.
July 9th, 2014 by Global Down Syndrome Foundation
2014 National Down Syndrome Congress Convention
July 11-13, 2014
JW Marriott – Indianapolis, IN
Global Down Syndrome Foundation – Booth #80
Linda Crnic Institute for Down Syndrome – Booth #79
Anna and John J. Sie Center for Down Syndrome – Booth #79
Catch up on the latest Global News! Sign up for our drawings and learn about our great medical care.
Impact for Families from a New Down Syndrome Clinic
Dr. Fran Hickey, Medical Director, Anna and Jon J. Sie Center for Down Syndrome
Friday, July 11, 3:30 pm – 5:00 pm, Room 202
Latest Legislative Developments: How They Impact You
Michelle Livingston, Sr. Director of Operations & Government Affairs, Global Down Syndrome Foundation, and Susan Goodman, Government Affairs Director, NDSC
Saturday, July 12, 8:30 am – 10:00 am, Room 201
Prenatal Testing: How to Get the Facts to Pregnant Women
Michelle Sie Whitten, Executive Director, Global Down Syndrome Foundation, and David Tolleson, Executive Director, NDSC
Saturday, July 12, 10:30 am – noon, Room 313
Biomedical Research on Down Syndrome and Alzheimer’s Disease:
the Many Paths to Improved Futures
Dr. Tom Blumenthal, Executive Director, Linda Crnic Institute for Down Syndrome
Saturday, July 12, 10:30 am – noon, Room 201
Gross Motor Skills in Children with Down Syndrome – Birth to Walking Skills
Pat Winders, Senior Physical Therapist, Anna and John J. Sie Center for Down Syndrome
Saturday, July 12, 10:30 am – noon, Room 202-203
Announcement: Global Down Syndrome Educational Grant Recipients
Join Global Down Syndrome Foundation and National Down Syndrome Congress
as we celebrate the 2014 grant winners!
Saturday, July 12, 1:30 pm – 3:00 pm, Plenary Session, Grand Ballroom 5
Gross Motor Skills in Children with Down Syndrome – Post-Walking Skills
Pat Winders, Senior Physical Therapist, Anna and John J. Sie Center for Down Syndrome
Saturday, July12, 3:30 pm – 5:00 pm, Room 202-203
Promoting Strengths and Resources in Teens and Adults with Down Syndrome
Dennis McGuire, PhD, Senior Consultant, Global Down Syndrome Foundation
Sunday, July 13, 10:30 am – noon, Grand Ballroom 8
April 22nd, 2014 by Global Down Syndrome Foundation
In recognition of April as Autism Awareness Month, the Global Down Syndrome Foundation held a Q&A with Dr. Tamim H. Shaikh, Associate Professor of Pediatrics at the University of Colorado Anschutz Medical Campus. Dr. Shaikh has received one of the inaugural Crnic Grand Challenge Grants to study the genetic modifiers of autism spectrum disorders in patients with Down syndrome.
1. What is the correlation between Down syndrome and autism?
A majority of individuals with Down syndrome have mild to moderate cognitive impairment or intellectual disability. But a significant number of children with Down syndrome have a more severe form of cognitive impairment with behavioral and developmental issues that are diagnosed as autism spectrum disorders (ASD). The incidence of ASD in individuals with Down syndrome is estimated to be as high as 10 percent, which is substantially higher than the general population.
2. Please describe the nature of your research.
We are interested in discovering the genetic factors which increase the risk of ASD in Down syndrome. We know that all individuals with DS have an extra copy of chromosome 21. But, the question that remains is whether there are additional genetic differences that are found only in individuals who have both Down syndrome and ASD and not in individuals with Down syndrome who do not have ASD. In order to accomplish this, we will analyze the genomes of children with only Down syndrome and those with Down syndrome and ASD using cutting-edge genome analysis tools.
3. How could your research end up benefiting people with Down syndrome?
Some phenotypes are consistently present in all individuals with Down syndrome, while some like ASD are not always present in all individuals with Down syndrome. If we are able to identify genetic factors that are unique to the individuals that have Down syndrome and ASD, this may help us develop therapeutic interventions to help alleviate social and behavioral impairments associated with ASD in individuals with Down syndrome.
4. How could your research end up benefiting people with autism?
It is possible that genetic factors that influence the risk of ASD in individuals with Down syndrome may be the same or similar to the genetic factors that influence the risk of ASD in the general population. Thus, the genetic factors identified in our study can be quickly tested in a larger population of individuals with ASD. Furthermore, our findings may also shed light on the types of genes and gene families that are important for proper brain development, providing potential candidate genes that can be tested in individuals with autism in the general population.
5. How important is the Crnic Supergroup in helping your research and promoting collaboration?
The Crnic Supergroup was a great idea! Its formation has been instrumental in promoting collaboration and exchange of ideas among a diverse group of researchers with different expertise. This has led to some very interesting discussions and innovative solutions toward improving the outcomes of individual research projects. My own research has benefited immensely by my interactions with members of the Supergroup. The different perspectives and expertise of Supergroup members have made me aware of new ways to think about my research and have often brought my attention to better methodologies and approaches that has improved the efficiency of my work. I think that many of the ideas and innovations resulting from our discussions have the potential to help the larger research community, whether they are studying Down syndrome or other conditions.
6. How important is the Crnic Institute funding for advancing research on the CU campus?
The Linda Crnic Institute has become an extremely important source of funding for research on the CU campus. This funding has succeeded in attracting a group of highly motivated and innovative scientists on the CU campus to explore how they can apply their expertise and experience to the of study Down syndrome. The seed funds provided by the Crnic Institute grants are critical to the development of research projects studying various aspects of Down syndrome, which remains one of the most underfunded areas of research. These pilot projects are important in generating preliminary data, which in the near future will allow researchers at CU to attract funding from the National Institutes of Health and other funding agencies.
7. Please tell us a little about yourself.
I grew up in Mumbai, India, where I received my undergraduate degree from Mumbai (Bombay) University, before coming to the U.S. for graduate studies. I got my doctoral degree in Molecular Genetics at the Louisiana State University Medical Center in New Orleans, and did my postdoctoral training in Human Genetics at the Children’s Hospital of Philadelphia (CHOP). Before coming to University of Colorado, I was an Assistant Professor at the University of Pennsylvania School of Medicine and CHOP. I am currently an Associate Professor in the Department of Pediatrics at the Anschutz Medical Campus of the University of Colorado. I have been studying the genetic basis of multiple birth defects for almost 20 years. One of my major research interests is studying conditions associated with chromosomal imbalances in which there is either loss (deletion), gain (duplication) or rearrangement (translocation, inversion) of genetic material. Most often, children with these types of genomic rearrangements will have multiple symptoms with intellectual disability, developmental delay, autism spectrum disorders and other behavioral symptoms being the most common findings along with many other highly variable phenotypes. We are interested in determining the genetic factors that contribute to the variability in symptoms observed in individuals with the same apparent genetic/genomic defect.
8. Is there anything else you’d like to add?
Down syndrome has many similarities to the conditions I study, as it is also characterized by having some consistent phenotypes but also many variable ones. Thanks to the funding from the Linda Crnic Institute, I am able to bring my expertise in studying genomic variation to the question of why many individuals with Down syndrome are at a higher risk of having autism spectrum disorders. This work would not have been possible without the support of the Crnic Institute.
April 10th, 2014 by Global Down Syndrome Foundation
We are continually impressed and humbled by the generosity, ingenuity and compassion of our donors. One recent example shines a light on how a high school student can make an adult-size impact.
Katie Shore (left, in picture above) of McConnellsburg High School in Pennsylvania raised more than $2,300 in five days for her senior project and donated the entire amount to the Global Down Syndrome Foundation!
It all started when Katie and her classmates were tasked to complete projects for their senior year. “Senior projects can be anything you want,” Katie said. “You can raise money or paint a room just as long as you get it approved by the principal, Todd Beatty.”
Inspired by her niece who has Down syndrome, Katie decided to raise money for the Global Down Syndrome Foundation and created a game that pitted each classroom in her school against the other. In the game, each classroom was assigned a bin to hold coins – pennies were counted as one point, and all silver coins were assigned a negative point value. The idea was for students to sabotage other classrooms by adding silver coins to their bins, which forces that class to add more pennies in order to boost their score.
At the end of the week, the classroom with the most points won a pizza party, and all the funds that were raised were donated to Global.
“My niece has Down syndrome, and people treat her different because of it,” Katie said. “She is a beautiful little girl, and I love her to death, and I want nothing more than for her to be happy. Kids make fun of her at school, and I see that she’s hurt. I just want to let her and all kids with Down syndrome know that people do care for them.”
The Global Down Syndrome Foundation would like to thank Katie Shore, her classmates and her school for this generous and thoughtful gift. The staff at Global will work hard to make sure this generous donation is used wisely and makes a difference. Global uses such funds to help fund life-changing medical care, research, events and programs like the I Love You Dance Parties, Dare to Play Football, Dare to Cheer and Advocacy promoting the civil and human rights of the differently-abled.
THANKS AGAIN, KATIE. YOU ARE AMAZING!
Pictured with Katie above are Alexandria Rexroth (center) and Reva Sounders (right)
February 25th, 2014 by Global Down Syndrome Foundation
In recognition of Febuary as American Heart Month, the Global Down Syndrome Foundation held a Q&A with Francis Hickey, the Medical Director at the Anna and John J. Sie Center for Down Syndrome at Children’s Hospital Colorado and Linda Crnic Institute for Down Syndrome. Dr. Hickey has received one of the inaugural Crnic Institute Grand Challenge Grants, to study the pharmacokinetics of morphine in post-operative cardiac patients with Down syndrome.
1. Why do so many children with Down syndrome need to have heart surgery?
This is due to an increased percentage of heart defects in children with Down syndrome. Among the different patient populations with cardiac disease, the population with Down syndrome is unique. Approximately 40% of this patient group is born with congenital heart disease, often requiring repair within the first several years of life.
2. Please describe the nature of your research, in simple terms.
The primary goal is to improve the morphine management in patients with Down syndrome compared to those without Down syndrome before and after cardiac surgery. Measurement of morphine levels will be correlated with clinical findings in the post-operative time period to help understand pain medication needs.
3. How could your research end up benefiting people with Down syndrome?
This information will be essential in the management of post-operative pain and sedation in children with Down syndrome and congenital heart disease, as well as in general all children with Down syndrome in their pain management. This knowledge may also open a window in the challenging use of psychoactive medications in individuals with Down syndrome. Knowledge about the metabolism of morphine in these patients will guide dosing and therefore limit the clinical post-op risks and side effects these patients are exposed to in all clinical situations where pain control is needed.
Also, identifying the genetic locations which are involved in the metabolism of morphine in this patient population will lead to future understanding of the pharmacogenomics of patients with Down syndrome and assist in the development of studies leading to goal-oriented sedation protocols.
4. February is Heart Awareness Month. What heart-health advice do you have for people with Down syndrome and their families?
As with all children: Exercise regularly, eat healthy, and follow up with cardiologist as recommended.
5. How important is the Crnic Institute Supergroup in promoting collaboration?
This exciting collaboration is one of the few interactions nationally of researchers interested with basic research in Down syndrome with clinical researchers interested with the care and improved outcome of individuals with Down syndrome.
6. How important is the collaboration with The Heart Institute at Children’s Hospital Colorado?
The Sie Center for Down Syndrome collaboration with The Heart Institute at Children’s Hospital Colorado is vital to the outcome of individuals with Down syndrome with heart issues from birth on. Both clinics have ongoing interaction regarding the care of these patients. This current study is an example the collaboration of the Heart institute and the Sie Center for Down Syndrome.
7. Please tell us a little about yourself.
I grew up in Boston and am currently Medical Director at the Sie Center for Down Syndrome at Children’s Hospital Colorado. I received my undergraduate degree from Harvard University, medical degree at the University of Cincinnati College of Medicine, and completed my pediatric residency at Cincinnati Children’s Hospital Medical Center, with my fellowship in Developmental Pediatrics at Boston Children’s Hospital. In addition to my academic position for 25 years, I also was a primary care physician for 21 years in Pediatrics, including many children with special needs, including children with Down syndrome and autism. My research and clinical interests include Down syndrome clinical research, Down syndrome with the co-morbidity of autism, functional MRI application in Down syndrome, clinical database, and preterm infant outcome. My wife, Kris, and I have four children; the youngest, James, has Down syndrome and continues to teach us about life.
8. Is there anything else you’d like to add?
Our group would like to thank the Crnic Institute and Global Down Syndrome Foundation for the opportunity to hopefully open the window of pain medicine management during cardiac surgery in patients with Down syndrome as well as pain management in general.
December 3rd, 2013 by Global Down Syndrome Foundation
Medical professionals, self-advocates and parents of people with Down syndrome will have access to 14 innovative educational programs across the U.S. and Puerto Rico through $155,000 in Global Down Syndrome Educational Grants.
This year’s grants, varying from $6,000 to $10,000 and benefiting eight local Down syndrome organizations, are being announced on International Day of Persons with Disabilities. In 2012, six organizations received grants from the program, which is a collaboration between the Global Down Syndrome Foundation (“Global”) and the National Down Syndrome Congress (“NDSC”).
“We are so pleased to be able to help local Down syndrome organizations and build capacity in our community,” said Michelle Sie Whitten, executive director of Global. “These organizations have great ideas that truly provide value to people with Down syndrome. They just need some encouragement and funds in order to deliver.”
Grant recipients detailed their ideas, budgets and goals for educational programs as part of their applications, which were reviewed by Global and NDSC for thoroughness, potential and sustainability. More than 50 applications have been submitted through the program.
The 2013 grant recipients are: Down Country, Down Syndrome Association of Brazos Valley, Down Syndrome Association of Central Florida, Down Syndrome Association of Central Oklahoma, Down Syndrome Association of Greater Richmond, Down Syndrome Association of Memphis & the Mid-South, Puerto Rico Down Syndrome Foundation and Red River Valley Down Syndrome Society.